CPRX — Catalyst Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $3.85bn
- $3.10bn
- $588.99m
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Solaris Energy rises on S&P SmallCap inclusion
Brief: Vamorolone Demonstrates On-Target Glucocorticoid Activity Without The Immunosuppression Characteristic Of Traditional Corticosteroids At Clinical Doses
Catalyst Pharmaceuticals' Q1 revenue slightly beats estimates on increased prescriber engagement
Brief: Catalyst Pharmaceuticals Q1 Revenue USD 149.4 Million Vs. IBES Estimate USD 148.2 Million
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics
Deals of the day-Mergers and acquisitions
Brief: Catalyst Pharma Says Angelini Pharma Deal Includes Termination Fee Of About $155.5 Mln
Brief: Angelini Pharma To Buy Catalyst Pharmaceuticals For $4.1 Bln
U.S. STOCKS ON THE MOVE-Catalyst Pharma, DoorDash, Tapestry
Deals of the day-Mergers and acquisitions
Catalyst Pharma climbs on $4.1 billion buyout deal